Sort
39,280 grants matching “leukemia”
RepServer: Antigen Receptor Repertoire Analysis Pipelines via the WWW
$641,471Lindsay G. Cowell · Ut Southwestern Medical Center · R01 · FY2014 · AI
Teens at Risk: Prenatal Cocaine and Postnatal Challenges
$641,387Virginia Delaney-Black · Wayne State University · R01 · FY2012 · DA
Studies of Host Cellular Proteins Required for viral Budding and release
$641,279Fadila Bouamr · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$641,266Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
$641,161Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Functional and translational studies of RUNX1 and CBFB in hematopoiesis
$641,111Paul Liu · National Human Genome Research Institute · ZIA · FY2015 · HG
Molecular mechanisms of allele-specific NRAS signaling and tumorigenesis
$640,969Christin E Burd · Ohio State University · R01 · FY2024 · CA
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in caner
$640,960G Greg Wang · Duke University · R01 · FY2025 · CA
Towards rational design of combination therapeutic targets
$640,892Kai Tan · Children'S Hosp Of Philadelphia · U01 · FY2021 · CA
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
$640,803Cristina Maria Fernandez-Valle · University Of Central Florida · R01 · FY2020 · DC
Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
$640,629Adam De Smith · University Of Southern California · R01 · FY2023 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$640,314Susan L Slager · Mayo Clinic Rochester · U01 · FY2010 · CA
Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights
$640,150Bing Zhang · Baylor College Of Medicine · U24 · FY2025 · CA
Overcoming resistance to menin patient mutations in leukemia
$640,135Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
$640,103Peter Kurre · Children'S Hosp Of Philadelphia · R01 · FY2023 · HL
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$639,740A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance
$639,689Neil P Shah · University Of California, San Francisco · R01 · FY2023 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$639,626Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$639,626Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$639,626Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Impact of low IL-10 levels at birth and leukemia risk
$639,604Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2015 · CA
Developmental Funds
$639,485Raphael E. Pollock · Ohio State University · P30 · FY2024 · CA
Developmental Funds
$639,483Raphael E. Pollock · Ohio State University · P30 · FY2023 · CA
Developmental Funds
$639,483Raphael E. Pollock · Ohio State University · P30 · FY2022 · CA
Developmental Funds
$639,483Raphael E. Pollock · Ohio State University · P30 · FY2021 · CA